Cargando…
Production of Monoclonal Antibodies in Plants for Cancer Immunotherapy
Plants are considered as an alternative platform for recombinant monoclonal antibody (mAb) production due to the improvement and diversification of transgenic techniques. The diversity of plant species offers a multitude of possibilities for the valorization of genetic resources. Moreover, plants ca...
Autores principales: | Moussavou, Ghislain, Ko, Kisung, Lee, Jeong-Hwan, Choo, Young-Kug |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4624878/ https://www.ncbi.nlm.nih.gov/pubmed/26550566 http://dx.doi.org/10.1155/2015/306164 |
Ejemplares similares
-
Growth Suppression of Colorectal Cancer by Plant-Derived Multiple mAb CO17-1A × BR55 via Inhibition of ERK1/2 Phosphorylation
por: Kwak, Dong Hoon, et al.
Publicado: (2014) -
Production of Recombinant Anti-Cancer Vaccines in Plants
por: Lee, Jeong Hwan, et al.
Publicado: (2017) -
Expression and In Vitro Function of Anti-Breast Cancer Llama-Based Single Domain Antibody VHH Expressed in Tobacco Plants
por: Park, Se Ra, et al.
Publicado: (2020) -
Anticancer Effects of Different Seaweeds on Human Colon and Breast Cancers
por: Moussavou, Ghislain, et al.
Publicado: (2014) -
Intracellular Reprogramming of Expression, Glycosylation, and Function of a Plant-Derived Antiviral Therapeutic Monoclonal Antibody
por: Lee, Jeong-Hwan, et al.
Publicado: (2013)